We are excited to find an ideologically aligned collaborative partner in IPERION. The GxP hosting space needs standardization of service expectations while still allowing for the flexibility that our industry demands.
Waltham, MA (PRWEB) October 01, 2013
MUSA, an experienced Life Sciences company specializing in scientific application support, technology and compliance, announced a partnership with Netherlands-based IPERION to work together to provide broader coverage for GxP cloud hosting. The companies plan to work together to provide their large enterprise customers with complete, robust hosting coverage in both the US and the EU. They plan to provide seamless hosting integration between MUSA’s Validated Cloud FDA-compliant hosting platform and IPERION’s compliant GxP hosting services in the EU.
“We are excited about the partnership between MUSA and IPERION,” says David LeCompte, Director of Business Development and Marketing for MUSA. “The two companies mirror each other in size, scope and expertise. Having validated hosting coverage in the EU will help us service large enterprise multi-national clients as well as smaller clients who want room to grow.”
“We are excited to find an ideologically aligned collaborative partner in IPERION. The GxP hosting space needs standardization of service expectations while still allowing for the flexibility that our industry demands. Having an EU partner who offers compliant IaaS, PaaS, GxP system support, validation and also application support helps us fulfill a much-needed gap in global coverage,” adds Doug Lantigua, Principal of MUSA.
“It means a great deal to us to be able to join forces with MUSA,” says Karel Bastiaanssen, CEO of IPERION. “Partnering with MUSA allows us to serve customers with a similar Validated Cloud offering for both EU and US. Additional benefits have been identified in the standardization of methodology and technology that both companies use to deploy cloud services to the market. It strengthens our position as a major player in this industry and will support our long-term strategy for global presence as an IS/IaaS supplier dedicated to the Life Sciences Industry.”